Is cardiometabolic risk improved by weight-loss drugs?

被引：10

作者：

Astrup, Arne ^{[1
]}

机构：

[1] Univ Copenhagen, Fac Life Sci, Dept Human Nutr, DK-1958 Frederiksberg, Denmark

来源：

LANCET | 2010年 / 376卷 / 9741期

关键词：

BLOOD-PRESSURE; BUPROPION;

D O I：

10.1016/S0140-6736(10)60999-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：567 / 568

页数：2

共 10 条

[1] [Anonymous], 2009, INF HEALTHC PROF VAR
[2] [Anonymous], QUEST ANSW SUSP MED
[3] Serious Adverse Reactions of Bupropion for Smoking Cessation Analysis of the French Pharmacovigilance Database from 2001 to 2004
Beyens, Marie-Noeelle
Guy, Claire
Mounier, Genevieve
Laporte, Sylvie
Ollagnier, Michel
[J]. DRUG SAFETY, 2008, 31 (11) : 1017 - 1026
[4] Bray GA, 2003, HDB HLTH CARE
[5] Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
Christensen, Robin
Kristensen, Pernelle Kruse
Bartels, Else Marie
Blidda, Henning
Astrup, Arne
[J]. LANCET, 2007, 370 (9600) : 1706 - 1713
[6] DAVIDSON J, 1989, J CLIN PSYCHIAT, V50, P256
[7] Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Greenway, Frank L.
Fujioka, Ken
Plodkowski, Raymond A.
Mudaliar, Sunder
Guttadauria, Maria
Erickson, Janelle
Kim, Dennis D.
Dunayevich, Eduardo
[J]. LANCET, 2010, 376 (9741) : 595 - 605
[8] Endogenous opioids inhibit ambulatory blood pressure during naturally occurring stress
McCubbin, JA
Bruehl, S
Wilson, JF
Sherman, JJ
Norton, JA
Colclough, G
[J]. PSYCHOSOMATIC MEDICINE, 1998, 60 (02): : 227 - 231
[9] A randomized, double-blind, placebo-controlled study of the effect of sustained-release bupropion on blood pressure in individuals with mild untreated hypertension
Thase, Michael E.
Haight, Barbara R.
Johnson, Marty C.
Hunt, Thomas
Krishen, Alok
Fleck, Richard J.
Modell, Jack G.
[J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (03) : 302 - 307
[10] 2010, LOW DOSE NALTREXONE

← 1 →